Clinical Trial Detail

NCT ID NCT02454842
Title Study for Treatment of Patients With EGFR Mutant, T790M-negative NSCLC
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Threshold Pharmaceuticals
Indications

lung non-small cell carcinoma

Therapies

TH-4000

Age Groups: adult

No variant requirements are available.